These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8272047)

  • 21. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 24. Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.
    Med Lett Drugs Ther; 2013 Aug; 55(1423):66-8. PubMed ID: 23959388
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multidrug-resistant tuberculosis. Remarks and reflections on a controversial subject of current utmost importance].
    Ausina V
    Med Clin (Barc); 1996 Jan; 106(1):15-8. PubMed ID: 8750536
    [No Abstract]   [Full Text] [Related]  

  • 26. Infectious disease. Approval of novel TB drug celebrated--with restraint.
    Cohen J
    Science; 2013 Jan; 339(6116):130. PubMed ID: 23307714
    [No Abstract]   [Full Text] [Related]  

  • 27. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.
    Bifani P; Mathema B; Kurepina N; Shashkina E; Bertout J; Blanchis AS; Moghazeh S; Driscoll J; Gicquel B; Frothingham R; Kreiswirth BN
    J Infect Dis; 2008 Jul; 198(1):90-4. PubMed ID: 18498237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple drug resistance of Mycobacterium tuberculosis].
    Yamada T
    Nihon Rinsho; 2001 Apr; 59(4):719-23. PubMed ID: 11304995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.
    Bozeman L; Burman W; Metchock B; Welch L; Weiner M;
    Clin Infect Dis; 2005 Feb; 40(3):386-91. PubMed ID: 15668861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003].
    Homolka J; Krejbich F; Havelková M
    Cas Lek Cesk; 2004; 143(12):836-9. PubMed ID: 15730215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium tuberculosis drug resistance: a call to action.
    Sudre P; Cohn DL
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):609-11. PubMed ID: 9712272
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 34. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
    Iavors'ka HV; Puhachevs'ka LP
    Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel drug target strategies against Mycobacterium tuberculosis.
    Murphy DJ; Brown JR
    Curr Opin Microbiol; 2008 Oct; 11(5):422-7. PubMed ID: 18801459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of native and lyophilized Loewenstein-Jensen's solid media in determining drug resistance on mycobacterium tuberculosis strains].
    Korneev AA; Golyshevskaia VI; Sevast'ianova EV; Safonova SG; Puzanov VA; Maslennikova IuV; Katulina NI; Stoiunin MB
    Probl Tuberk; 1999; (4):25-7. PubMed ID: 10479928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
    Rivoire N; Ravololonandriana P; Rasolonavalona T; Martin A; Portaels F; Ramarokoto H; Rasolofo Razanamparany V
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):683-8. PubMed ID: 17519102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.